ADMA Biologics, Inc. (ADMA)
USD 17.84
(-8.3%)
USD 17.84
(-8.3%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 90.06 Million USD | 32.6% |
| 2022 | 67.92 Million USD | 31.04% |
| 2021 | 51.83 Million USD | 24.15% |
| 2020 | 41.74 Million USD | -27.99% |
| 2019 | 57.97 Million USD | 170.05% |
| 2018 | 21.46 Million USD | 15803.06% |
| 2017 | -136.72 Thousand USD | -101.32% |
| 2016 | 10.34 Million USD | 95.55% |
| 2015 | 5.28 Million USD | 337.31% |
| 2014 | -2.22 Million USD | 89.42% |
| 2013 | -21.07 Million USD | -146.0% |
| 2012 | -8.56 Million USD | -187.33% |
| 2011 | 9.8 Million USD | 36.47% |
| 2010 | 7.18 Million USD | 154.89% |
| 2009 | 2.82 Million USD | -78.81% |
| 2008 | 13.31 Million USD | 390.63% |
| 2007 | -4.58 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 96.1 Million USD | 6.7% |
| 2024 Q2 | 53.15 Million USD | -44.69% |
| 2023 Q2 | 89 Million USD | 2.87% |
| 2023 Q3 | 78.81 Million USD | -11.44% |
| 2023 Q1 | 86.52 Million USD | 27.38% |
| 2023 FY | 90.06 Million USD | 32.6% |
| 2023 Q4 | 90.06 Million USD | 14.27% |
| 2022 Q1 | 76.85 Million USD | 48.28% |
| 2022 Q3 | 117.81 Million USD | 19.19% |
| 2022 FY | 67.92 Million USD | 31.04% |
| 2022 Q4 | 67.92 Million USD | -42.35% |
| 2022 Q2 | 98.84 Million USD | 28.61% |
| 2021 Q4 | 51.83 Million USD | -23.07% |
| 2021 FY | 51.83 Million USD | 24.15% |
| 2021 Q1 | 38.18 Million USD | -8.53% |
| 2021 Q2 | 58.92 Million USD | 54.32% |
| 2021 Q3 | 67.36 Million USD | 14.33% |
| 2020 Q3 | 40.5 Million USD | 69.19% |
| 2020 Q2 | 23.94 Million USD | 877.02% |
| 2020 Q1 | -3.08 Million USD | -105.31% |
| 2020 FY | 41.74 Million USD | -27.99% |
| 2020 Q4 | 41.74 Million USD | 3.07% |
| 2019 Q2 | 10.38 Million USD | -74.62% |
| 2019 Q4 | 57.97 Million USD | 59.64% |
| 2019 FY | 57.97 Million USD | 170.05% |
| 2019 Q1 | 40.9 Million USD | 90.52% |
| 2019 Q3 | 36.31 Million USD | 249.84% |
| 2018 Q2 | -11.49 Million USD | -167.19% |
| 2018 FY | 21.46 Million USD | 15803.06% |
| 2018 Q4 | 21.46 Million USD | 1269.0% |
| 2018 Q1 | 17.1 Million USD | 12612.33% |
| 2018 Q3 | 1.56 Million USD | 113.64% |
| 2017 Q4 | -136.72 Thousand USD | -100.78% |
| 2017 Q3 | 17.55 Million USD | 148.32% |
| 2017 Q2 | 7.07 Million USD | -34.48% |
| 2017 Q1 | 10.79 Million USD | 4.32% |
| 2017 FY | -136.72 Thousand USD | -101.32% |
| 2016 Q3 | 12.16 Million USD | 65.82% |
| 2016 Q1 | 6.93 Million USD | 31.11% |
| 2016 Q2 | 7.33 Million USD | 5.76% |
| 2016 Q4 | 10.34 Million USD | -14.95% |
| 2016 FY | 10.34 Million USD | 95.55% |
| 2015 Q3 | 6.42 Million USD | -16.14% |
| 2015 Q1 | -1.47 Million USD | 33.73% |
| 2015 Q2 | 7.66 Million USD | 618.68% |
| 2015 FY | 5.28 Million USD | 337.31% |
| 2015 Q4 | 5.28 Million USD | -17.67% |
| 2014 Q2 | -7.95 Million USD | 52.16% |
| 2014 Q4 | -2.22 Million USD | 42.71% |
| 2014 Q3 | -3.89 Million USD | 51.11% |
| 2014 FY | -2.22 Million USD | 89.42% |
| 2014 Q1 | -16.63 Million USD | 21.06% |
| 2013 Q1 | -5.3 Million USD | 38.05% |
| 2013 Q3 | -326.15 Thousand USD | 87.55% |
| 2013 Q4 | -21.07 Million USD | -6361.3% |
| 2013 FY | -21.07 Million USD | -146.0% |
| 2013 Q2 | -2.62 Million USD | 50.63% |
| 2012 Q2 | -12.79 Million USD | 9.54% |
| 2012 FY | -8.56 Million USD | -187.33% |
| 2012 Q4 | -8.56 Million USD | 19.4% |
| 2012 Q3 | -10.62 Million USD | 16.92% |
| 2012 Q1 | -14.14 Million USD | -174961.44% |
| 2011 Q1 | 5.8 Million USD | 20.5% |
| 2011 Q4 | -8079.00 USD | -36.72% |
| 2011 FY | 9.8 Million USD | 36.47% |
| 2011 Q3 | -5909.00 USD | -100.06% |
| 2011 Q2 | 9.8 Million USD | 69.08% |
| 2010 Q2 | 12.34 Million USD | 227.13% |
| 2010 Q4 | 4.81 Million USD | -3.49% |
| 2010 Q3 | 4.98 Million USD | -59.59% |
| 2010 Q1 | 3.77 Million USD | 464.29% |
| 2010 FY | 7.18 Million USD | 154.89% |
| 2009 Q2 | 2.82 Million USD | 186.77% |
| 2009 FY | 2.82 Million USD | -78.81% |
| 2009 Q4 | -1.03 Million USD | -262.38% |
| 2009 Q3 | 638 Thousand USD | -77.38% |
| 2009 Q1 | -3.25 Million USD | -470.18% |
| 2008 Q4 | -570 Thousand USD | 0.0% |
| 2008 Q1 | 4.48 Million USD | 1287.57% |
| 2008 FY | 13.31 Million USD | 390.63% |
| 2008 Q2 | 13.31 Million USD | 196.52% |
| 2007 Q4 | -378 Thousand USD | -153.77% |
| 2007 Q1 | -13.09 Million USD | -153.36% |
| 2007 Q2 | -4.58 Million USD | 65.01% |
| 2007 FY | -4.58 Million USD | 0.0% |
| 2007 Q3 | 703 Thousand USD | 115.35% |
| 2006 Q4 | -5.16 Million USD | 32.34% |
| 2006 Q3 | -7.63 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 261.005% |
| Alkermes plc | -166.73 Million USD | 154.016% |
| Agenus Inc. | 274.13 Million USD | 67.146% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 95.183% |
| Aptorum Group Limited | 1.35 Million USD | -6536.916% |
| Ardelyx, Inc. | 34.51 Million USD | -160.97% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -2004.346% |
| Bicycle Therapeutics plc | -481.46 Million USD | 118.707% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -149.056% |
| ChromaDex Corporation | -24.04 Million USD | 474.526% |
| Chimerix, Inc. | -25.51 Million USD | 452.965% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -1192.552% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 480.394% |
| CRISPR Therapeutics AG | -150.84 Million USD | 159.708% |
| Precision BioSciences, Inc. | -85.41 Million USD | 205.451% |
| Dyadic International, Inc. | -6.37 Million USD | 1512.114% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 665.28% |
| Fortress Biotech, Inc. | 7.66 Million USD | -1075.029% |
| Lantern Pharma Inc. | -21.7 Million USD | 514.988% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 181.48% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 1154.245% |
| Incyte Corporation | -3.17 Billion USD | 102.837% |
| IO Biotech, Inc. | -140.69 Million USD | 164.013% |
| Jaguar Health, Inc. | 29.39 Million USD | -206.441% |
| Novavax, Inc. | -298.29 Million USD | 130.194% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -1587.577% |
| Opthea Limited | 28.15 Million USD | -219.866% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 636.458% |
| ContextLogic Inc. | -232 Million USD | 138.822% |
| MiMedx Group, Inc. | -33.9 Million USD | 365.674% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -783.433% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 3987.136% |
| NextCure, Inc. | -6.47 Million USD | 1490.551% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 278.345% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 1511.914% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -640.475% |
| Vaxcyte, Inc. | -368.22 Million USD | 124.459% |
| PDS Biotechnology Corporation | -32.7 Million USD | 375.356% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -421.276% |
| Pharming Group N.V. | 109.8 Million USD | 17.976% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 617.74% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 151.399% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 586.321% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 586.321% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 1368.535% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 1636.962% |
| Acelyrin, Inc. | -216.9 Million USD | 141.524% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 1705.378% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 5324.246% |
| Summit Therapeutics Inc. | 34.67 Million USD | -159.751% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 1423.916% |
| Senti Biosciences, Inc. | 1.74 Million USD | -5076.207% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 148.788% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 216.288% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 1585.747% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -90174.534% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -14241.72% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 176.949% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 153.536% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 18.764% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 1285.703% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 169.757% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -1206.327% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 137.162% |
| Immix Biopharma, Inc. | -17.5 Million USD | 614.375% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 128.439% |
| MEI Pharma, Inc. | -3.7 Million USD | 2530.931% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -619.894% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 44.315% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -224.06% |
| Fortress Biotech, Inc. | 7.66 Million USD | -1075.029% |
| Precigen, Inc. | -481 Thousand USD | 18824.74% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -539.628% |
| AlloVir, Inc. | -62.69 Million USD | 243.664% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 261.948% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -46.055% |
| ImmuCell Corporation | 10.99 Million USD | -719.485% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 158.429% |
| Onconetix, Inc. | 5.33 Million USD | -1589.338% |
| PureTech Health plc | -167.19 Million USD | 153.868% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 395.686% |
| Elevation Oncology, Inc. | -19.11 Million USD | 571.106% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 1934.712% |
| Seer, Inc. | -4.24 Million USD | 2224.198% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 474.697% |
| Innoviva, Inc. | 255.56 Million USD | 64.758% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 261.224% |
| ESSA Pharma Inc. | -33.62 Million USD | 367.881% |
| GlycoMimetics, Inc. | -40.98 Million USD | 319.757% |
| GT Biopharma, Inc. | -1.02 Million USD | 8921.352% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 232.874% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -47.03% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 167.174% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 750.014% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 411.949% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 119655.579% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 391.835% |
| Aptose Biosciences Inc. | -8.19 Million USD | 1199.055% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 2978.411% |
| Soligenix, Inc. | -4.95 Million USD | 1918.928% |
| Century Therapeutics, Inc. | 847 Thousand USD | -10533.53% |
| Kura Oncology, Inc. | -20.11 Million USD | 547.689% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 320.07% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 1172.47% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -4844.077% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 2917.204% |
| Autolus Therapeutics plc | -186.59 Million USD | 148.267% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 282.675% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 132.657% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -162.828% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 45.205% |
| GRI Bio, Inc. | -1.79 Million USD | 5120.401% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 1102.622% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 370.818% |
| IGM Biosciences, Inc. | -72.6 Million USD | 224.048% |
| INmune Bio, Inc. | -25.41 Million USD | 454.437% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 40.334% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 277.789% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 654.274% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 3221.952% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -136.922% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 318.686% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -182.471% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 76.17% |
| Verastem, Inc. | -37.27 Million USD | 341.606% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 1092.682% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 273.665% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 695.084% |
| Histogen Inc. | -7.48 Million USD | 1302.965% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 516.841% |
| Surrozen, Inc. | -32.66 Million USD | 375.735% |
| Organovo Holdings, Inc. | -1.5 Million USD | 6076.51% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 2242.649% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -375.026% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -3342.89% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -2067.132% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 1174.626% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 307.325% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 717.87% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 128.431% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 12573.479% |
| Apollomics, Inc. | -27.39 Million USD | 428.768% |
| Amarin Corporation plc | -191.04 Million USD | 147.145% |
| Mesoblast Limited | 55.96 Million USD | -60.938% |
| Turnstone Biologics Corp. | -14.58 Million USD | 717.567% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 456.105% |
| Synaptogenix, Inc. | -28.66 Million USD | 414.24% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 9722.436% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -84.819% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 10547.413% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 1339.54% |
| Exelixis, Inc. | -73.05 Million USD | 223.294% |
| Better Therapeutics, Inc. | -860 Thousand USD | 10572.791% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 475.072% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 137.314% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -12136.131% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 1310.868% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -7082.297% |
| Gritstone bio, Inc. | 39.49 Million USD | -128.073% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 207.093% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 3521.778% |
| Avid Bioservices, Inc. | 169.72 Million USD | 46.935% |
| Insmed Incorporated | 721.62 Million USD | 87.519% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 1085.242% |
| MediWound Ltd. | -5.32 Million USD | 1792.334% |
| OmniAb, Inc. | 9.2 Million USD | -878.659% |
| Alector, Inc. | -35.63 Million USD | 352.732% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -4.763% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 1927.638% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -580.308% |
| Zai Lab Limited | -775 Million USD | 111.621% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 73.553% |
| Aura Biosciences, Inc. | -21.52 Million USD | 518.425% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 209.197% |
| Immunic, Inc. | -45.34 Million USD | 298.646% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 146.614% |
| Veracyte, Inc. | -203.82 Million USD | 144.188% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 85.89% |
| FibroGen, Inc. | 56.76 Million USD | -58.659% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -911.409% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 3285.829% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 4450.283% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 98.038% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 2795.78% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 154.268% |
| TG Therapeutics, Inc. | 17.86 Million USD | -404.232% |
| Galecto, Inc. | -21.21 Million USD | 524.519% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 478.667% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 94.261% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 468.037% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 882.706% |
| XBiotech Inc. | -200.02 Million USD | 145.028% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 207.093% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -1889.09% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 355.412% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 216.639% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -1482.604% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 152.851% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 197.501% |
| Vaxxinity, Inc. | 10.13 Million USD | -788.926% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 87.767% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 936.458% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 236.555% |
| NexImmune, Inc. | -3.13 Million USD | 2974.163% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 2708.588% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 696.012% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 432.347% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 1103.403% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 72398.615% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 321.991% |
| Ainos, Inc. | 4.07 Million USD | -2108.622% |
| Pluri Inc. | 22.82 Million USD | -294.525% |
| Prothena Corporation plc | -608.34 Million USD | 114.805% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 175.841% |
| Celularity Inc. | 65.19 Million USD | -38.159% |
| Rallybio Corporation | -24.1 Million USD | 473.687% |
| Cue Biopharma, Inc. | -33.81 Million USD | 366.318% |
| MeiraGTx Holdings plc | -40.3 Million USD | 323.478% |
| Omeros Corporation | 331.17 Million USD | 72.804% |
| Humacyte, Inc. | -22.48 Million USD | 500.543% |
| Immunocore Holdings plc | -358.59 Million USD | 125.116% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 466.494% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 391.466% |
| Blueprint Medicines Corporation | 702.83 Million USD | 87.185% |
| CalciMedica, Inc. | -5.53 Million USD | 1728.68% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 147.851% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 981.79% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 324.957% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 370.851% |
| Pulmatrix, Inc. | -10.41 Million USD | 964.606% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 1606.876% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 336.133% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 180.848% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 250.25% |
| Cytokinetics, Incorporated | 642.37 Million USD | 85.979% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 1646.728% |
| Nutriband Inc. | -251.65 Thousand USD | 35889.189% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 363.976% |
| Vor Biopharma Inc. | 4.3 Million USD | -1994.558% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 101.492% |
| Evogene Ltd. | -19.63 Million USD | 558.725% |
| ProKidney Corp. | -56.23 Million USD | 260.157% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 285.047% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 1075.037% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 93.396% |
| CorMedix Inc. | -43.05 Million USD | 309.2% |
| BioLineRx Ltd. | 7.33 Million USD | -1127.726% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 427.93% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -95.172% |
| Atai Life Sciences N.V. | -28.55 Million USD | 415.379% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -3937.876% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 494.749% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -407.843% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 219.97% |
| MediciNova, Inc. | -50.78 Million USD | 277.353% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 214.29% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 400482.307% |
| GeoVax Labs, Inc. | -6.45 Million USD | 1495.812% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 145.073% |
| Biomea Fusion, Inc. | -166.57 Million USD | 154.071% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 150.323% |
| Mereo BioPharma Group plc | -51.46 Million USD | 274.991% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 194.962% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 130.66% |
| Absci Corporation | -72.59 Million USD | 224.061% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -1872.536% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 138.418% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 195.6% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 194.117% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 330.507% |
| Allakos Inc. | -24.97 Million USD | 460.625% |
| Imunon, Inc. | -4.21 Million USD | 2237.379% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 710.948% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 166.518% |
| BioAtla, Inc. | -109.01 Million USD | 182.621% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -12136.131% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 9691.693% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -652.683% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 524.78% |
| XOMA Corporation | -29 Million USD | 410.572% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 643.877% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 1098.957% |
| aTyr Pharma, Inc. | -7.44 Million USD | 1309.102% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 172.263% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 143.267% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 210.133% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 197.093% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 10582.737% |
| Akari Therapeutics, Plc | -3.84 Million USD | 2442.419% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -5449.729% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 93.478% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 7680.452% |
| UroGen Pharma Ltd. | 4.39 Million USD | -1951.15% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 20.633% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -125057.722% |
| Orgenesis Inc. | 21.78 Million USD | -313.45% |
| Entera Bio Ltd. | -10.62 Million USD | 947.361% |
| GH Research PLC | -78.07 Million USD | 215.355% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 504.101% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 437.845% |
| Xencor, Inc. | 29.64 Million USD | -203.825% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 4672.315% |
| Replimune Group, Inc. | 1.41 Million USD | -6278.612% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 36875.442% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 171.245% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 7680.452% |
| Portage Biotech Inc. | -4.98 Million USD | 1908.191% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 400482.307% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 236.212% |
| OncoCyte Corporation | -6.56 Million USD | 1472.33% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -9936.182% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 2077.021% |
| Purple Biotech Ltd. | -14.13 Million USD | 737.049% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 479.129% |
| scPharmaceuticals Inc. | -6.54 Million USD | 1476.104% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 639.571% |
| HilleVax, Inc. | -165.48 Million USD | 154.425% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 3648.7% |
| Tharimmune, Inc. | -10.93 Million USD | 923.622% |
| Genprex, Inc. | -6.73 Million USD | 1436.761% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 124.421% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 201.816% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 6528.694% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 2815.329% |
| OKYO Pharma Limited | -826.84 Thousand USD | 10992.691% |
| Savara Inc. | 153 Thousand USD | -58766.667% |
| Curis, Inc. | -23.88 Million USD | 477.05% |
| Daré Bioscience, Inc. | -5.15 Million USD | 1846.172% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 11706.264% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 1550.805% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -7500.506% |
| BeiGene, Ltd. | -2.25 Billion USD | 103.997% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -629.959% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 114.809% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 148.531% |
| Erasca, Inc. | -37.21 Million USD | 342.009% |
| bluebird bio, Inc. | 108.57 Million USD | 17.044% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 7093.283% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 76.22% |
| DBV Technologies S.A. | -126.98 Million USD | 170.926% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 7093.283% |
| Moderna, Inc. | -2.9 Billion USD | 103.098% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 970.035% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 928.727% |
| Molecular Templates, Inc. | 707 Thousand USD | -12639.18% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 387.1% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 74.015% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 209.754% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 198.186% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 379.084% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 362.003% |
| MacroGenics, Inc. | -66.98 Million USD | 234.457% |
| RenovoRx, Inc. | -1.17 Million USD | 7778.261% |
| Adicet Bio, Inc. | -138.78 Million USD | 164.895% |
| Prime Medicine, Inc. | -27.94 Million USD | 422.344% |
| Aditxt, Inc. | 18.12 Million USD | -397.029% |
| Adagene Inc. | -87.62 Million USD | 202.783% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 2262.227% |
| Quantum-Si incorporated | -118.55 Million USD | 175.969% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -150.149% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 1305.027% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 285.669% |
| SciSparc Ltd. | -2.06 Million USD | 4461.55% |
| Vericel Corporation | 1.27 Million USD | -6952.937% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 851.069% |
| Minerva Neurosciences, Inc. | 41 Million USD | -119.65% |
| Generation Bio Co. | 31.44 Million USD | -186.397% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 151.359% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 391.259% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 22.752% |
| Invivyd, Inc. | -198.47 Million USD | 145.379% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 199.774% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 3856.368% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 227.23% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 1419.648% |
| 2seventy bio, Inc. | 181.71 Million USD | 50.436% |
| Clene Inc. | 3.34 Million USD | -2596.587% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 1091.621% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 518.697% |
| GeoVax Labs, Inc. | -6.45 Million USD | 1495.812% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 126.173% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 446.412% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 49.306% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 2301.259% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -1700.6% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 1829.046% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 169.12% |
| Evaxion Biotech A/S | 5.28 Million USD | -1603.587% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 180.01% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 168.61% |
| Trevena, Inc. | 2.25 Million USD | -3888.751% |
| Surrozen, Inc. | -32.66 Million USD | 375.735% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 274.851% |
| Cingulate Inc. | 3.08 Million USD | -2821.676% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 3166.599% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -1153.179% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 1069.366% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 213.543% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 168.516% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 185.337% |
| Clearmind Medicine Inc. | -3.94 Million USD | 2384.41% |
| Kronos Bio, Inc. | -36.05 Million USD | 349.809% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -857.232% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -6076.828% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 266.002% |
| Statera Biopharma, Inc. | 14.41 Million USD | -524.747% |
| ImmunityBio, Inc. | 618.22 Million USD | 85.431% |
| Korro Bio, Inc. | -132.94 Million USD | 167.748% |
| Kineta, Inc. | -4.54 Million USD | 2083.396% |
| BioVie Inc. | -17.73 Million USD | 607.919% |
| Codexis, Inc. | -43.27 Million USD | 308.144% |
| Celularity Inc. | 65.19 Million USD | -38.159% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 2942.095% |
| Celcuity Inc. | 6.78 Million USD | -1227.72% |
| Virax Biolabs Group Limited | -3.36 Million USD | 2776.597% |
| Cibus, Inc. | -8.07 Million USD | 1214.954% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 2229.723% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -1870.81% |
| IN8bio, Inc. | -16.38 Million USD | 649.552% |
| Kodiak Sciences Inc. | -103.87 Million USD | 186.706% |
| Annexon, Inc. | -193.75 Million USD | 146.484% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -250083.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 614.692% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 2663.792% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 91.457% |
| Eyenovia, Inc. | 1.25 Million USD | -7055.467% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -234.756% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 2877.243% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 370.9% |
| Arcellx, Inc. | -296.95 Million USD | 130.33% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 561.735% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 252.978% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 534.535% |
| Moolec Science SA | 117.61 Thousand USD | -76476.316% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 334.553% |
| Geron Corporation | 14.76 Million USD | -510.162% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 337.528% |
| Royalty Pharma plc | 5.65 Billion USD | 98.408% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 163.686% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 1388.604% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 1779.44% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 163.999% |
| Humacyte, Inc. | -22.48 Million USD | 500.543% |
| Structure Therapeutics Inc. | -124.33 Million USD | 172.436% |
| 89bio, Inc. | -289.05 Million USD | 131.159% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 456.81% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 5151.374% |
| Genelux Corporation | -6.89 Million USD | 1405.494% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 389.984% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -7.736% |
| Notable Labs, Ltd. | -9.77 Million USD | 1021.297% |
| Liquidia Corporation | -80.17 Million USD | 212.335% |
| Mustang Bio, Inc. | -3.73 Million USD | 2510.76% |
| Immunovant, Inc. | -635.22 Million USD | 114.179% |
| Quantum-Si incorporated | -118.55 Million USD | 175.969% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 612.788% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 2273.932% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -1022.038% |
| Acasti Pharma Inc. | -23 Million USD | 491.506% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 2774.781% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 654.274% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 165.388% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 2990.101% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 505.119% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 585.034% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 153.206% |
| PepGen Inc. | -60.67 Million USD | 248.452% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 492.0% |
| United Therapeutics Corporation | -507.7 Million USD | 117.74% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 570.909% |
| Solid Biosciences Inc. | -47.75 Million USD | 288.62% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 10547.413% |
| Immuneering Corporation | -54.94 Million USD | 263.927% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 2242.649% |
| Silo Pharma, Inc. | -3.52 Million USD | 2655.566% |
| Belite Bio, Inc | -87.27 Million USD | 203.203% |
| XOMA Corporation | -29 Million USD | 410.572% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 227.397% |
| Bionomics Limited | 227 Million USD | 60.325% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 177.455% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 3655.705% |
| uniQure N.V. | -102.95 Million USD | 187.484% |
| Cassava Sciences, Inc. | -121.13 Million USD | 174.351% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 2262.227% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -119.936% |
| Forte Biosciences, Inc. | -11.96 Million USD | 852.997% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 3010.801% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -84867.925% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 2877.243% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -911.409% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 1314.482% |
| Altimmune, Inc. | -134.48 Million USD | 166.97% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 54.527% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 3655.705% |
| Compugen Ltd. | -12.9 Million USD | 797.97% |
| Peak Bio, Inc. | 10.34 Million USD | -771.031% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 31925.442% |
| Benitec Biopharma Inc. | -50.58 Million USD | 278.059% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 186.321% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -358.468% |
| Zura Bio Limited | -99.8 Million USD | 190.241% |
| PolyPid Ltd. | 6.17 Million USD | -1359.741% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -21.514% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -358.468% |
| Instil Bio, Inc. | 75.35 Million USD | -19.518% |
| argenx SE | -2.02 Billion USD | 104.439% |
| Immunome, Inc. | -97.02 Million USD | 192.824% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 500.382% |
| Verona Pharma plc | -220.44 Million USD | 140.857% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 225.54% |
| Shattuck Labs, Inc. | -121.42 Million USD | 174.175% |
| CervoMed Inc. | -7.79 Million USD | 1255.752% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 148.553% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 2159.593% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 168.366% |
| Moolec Science SA | 117.61 Thousand USD | -76476.316% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 4036.491% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -466.511% |
| AnaptysBio, Inc. | -18.15 Million USD | 596.204% |
| Design Therapeutics, Inc. | -18.15 Million USD | 596.231% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 227.969% |
| NeurAxis, Inc. | 145.7 Thousand USD | -61716.06% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -701.87% |
| Lumos Pharma, Inc. | -28.49 Million USD | 416.099% |
| Achilles Therapeutics plc | -126.92 Million USD | 170.961% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 225.54% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 13835.226% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 533.555% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -6076.828% |
| Nutriband Inc. | -251.65 Thousand USD | 35889.189% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 783.821% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 1310.565% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 73.525% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -279.465% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 120.128% |
| Palisade Bio, Inc. | -12.06 Million USD | 846.63% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 164.19% |
| Beam Therapeutics Inc. | -262.72 Million USD | 134.282% |
| Neurogene Inc. | -131.95 Million USD | 168.255% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -312.844% |
| AEON Biopharma, Inc. | -4.88 Million USD | 1945.615% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 123.878% |
| Sesen Bio, Inc. | -112.55 Million USD | 180.021% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 190.192% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 3936.199% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 330.785% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 208.146% |
| Athira Pharma, Inc. | -88.99 Million USD | 201.199% |
| Vaccinex, Inc. | -1.28 Million USD | 7092.702% |
| HCW Biologics Inc. | 2.85 Million USD | -3052.825% |
| XOMA Corporation | -29 Million USD | 410.572% |
| Nektar Therapeutics | 210.24 Million USD | 57.16% |
| Arvinas, Inc. | -313.8 Million USD | 128.702% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -5449.729% |
| Merus N.V. | -192.88 Million USD | 146.694% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -50.148% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 1398.155% |
| Rezolute, Inc. | -68.16 Million USD | 232.124% |
| Clene Inc. | 3.34 Million USD | -2596.587% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 782.991% |
| BeyondSpring Inc. | -13.75 Million USD | 754.787% |
| Synlogic, Inc. | -6.68 Million USD | 1447.285% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -7842.328% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 1165.24% |
| Peak Bio, Inc. | 10.34 Million USD | -771.031% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 209.277% |
| Krystal Biotech, Inc. | -350.23 Million USD | 125.716% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 27.439% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 153.295% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 2952.768% |
| MannKind Corporation | 143.89 Million USD | 37.41% |
| Ikena Oncology, Inc. | -109.15 Million USD | 182.511% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 1289.618% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 372.103% |
| Gossamer Bio, Inc. | 180.35 Million USD | 50.062% |
| CohBar, Inc. | -5.93 Million USD | 1618.632% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 402.763% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -1872.536% |
| Legend Biotech Corporation | -949.39 Million USD | 109.487% |
| Mural Oncology plc | -255.84 Million USD | 135.204% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -179.578% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 2011.969% |
| Disc Medicine, Inc. | -358.28 Million USD | 125.138% |
| Champions Oncology, Inc. | 4.81 Million USD | -1771.696% |
| REGENXBIO Inc. | 54.76 Million USD | -64.45% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 33593.364% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 159.637% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 1099.4% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 211.629% |
| Vaxart, Inc. | -8.24 Million USD | 1192.901% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 279.486% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 170.826% |
| Cellectis S.A. | -43.85 Million USD | 305.372% |
| Longeveron Inc. | -2.9 Million USD | 3197.18% |
| Repare Therapeutics Inc. | -107.85 Million USD | 183.504% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 90.699% |
| Inozyme Pharma, Inc. | 12 Million USD | -650.3% |
| Revolution Medicines, Inc. | -608.2 Million USD | 114.809% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 7422.439% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 133.972% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 160.015% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 675.612% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 12271.081% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 100.942% |
| Denali Therapeutics Inc. | -74.86 Million USD | 220.305% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 851.069% |
| Veru Inc. | 4.77 Million USD | -1784.238% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 900.871% |
| Cingulate Inc. | 3.08 Million USD | -2821.676% |
| Passage Bio, Inc. | 4.58 Million USD | -1864.362% |
| Context Therapeutics Inc. | -14.44 Million USD | 723.302% |
| Exicure, Inc. | 5.84 Million USD | -1439.853% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 139.095% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 327.612% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -473.998% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 253.119% |
| Nuvalent, Inc. | -335.38 Million USD | 126.854% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -5093.096% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 220.923% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 1113.116% |
| OmniAb, Inc. | 9.2 Million USD | -878.659% |
| Anew Medical, Inc. | 1.43 Million USD | -6187.483% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -449.795% |
| Lipocine Inc. | -4.75 Million USD | 1994.295% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 182.006% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -491.333% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 277.789% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -261.827% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 1440.068% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 236.822% |
| Ocugen, Inc. | -32.52 Million USD | 376.947% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 205.248% |
| Q32 Bio Inc. | -37.94 Million USD | 337.341% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 14441.72% |
| Alumis Inc. Common Stock | -13.52 Million USD | 765.725% |
| Equillium, Inc. | -22.39 Million USD | 502.224% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 452.261% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 376.049% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 36429.387% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 32.808% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -2716.323% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -27322.277% |
| Dominari Holdings Inc. | 195 Thousand USD | -46087.692% |
| Edesa Biotech, Inc. | -5.26 Million USD | 1810.035% |
| vTv Therapeutics Inc. | -8.91 Million USD | 1110.048% |
| Bio-Techne Corporation | 267.74 Million USD | 66.362% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 655.654% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 176.266% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 1171.831% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 811.928% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 136.744% |
| Nkarta, Inc. | 57.29 Million USD | -57.186% |
| BioCardia, Inc. | 212 Thousand USD | -42383.962% |
| Iterum Therapeutics plc | 13.43 Million USD | -570.234% |